T.Man Pharmaceutical PCL (BKK:TMAN)

Thailand flag Thailand · Delayed Price · Currency is THB
12.50
-0.10 (-0.79%)
Last updated: Mar 4, 2026, 3:37 PM ICT
0.81%
Market Cap 5.04B
Revenue (ttm) 2.53B
Net Income (ttm) 523.07M
Shares Out 400.00M
EPS (ttm) 1.31
PE Ratio 9.64
Forward PE 9.69
Dividend 0.32 (2.54%)
Ex-Dividend Date May 8, 2026
Volume 759,366
Average Volume 480,422
Open 12.30
Previous Close 12.60
Day's Range 11.80 - 12.50
52-Week Range 9.90 - 13.60
Beta n/a
RSI 62.99
Earnings Date Feb 25, 2026

About T.Man Pharmaceutical PCL

T.Man Pharmaceutical Public Company Limited manufactures and sells pharmaceuticals and health care products in Thailand. The company operates through three segments: Manufactured Products Under Own Brand, Manufactured Products Under Third Parties’ Brand, and Trading Products. It offers antibacterial, central nervous system, corticosteroid, chronic diseases, gastrointestinal, respiratory, and musculoskeletal drugs, as well as medical devices, vaginal suppositories, dermatological, mouth, and throat products. The company also provides herbal and ... [Read more]

Sector Healthcare
Founded 1991
Employees 944
Stock Exchange Stock Exchange of Thailand
Ticker Symbol TMAN
Full Company Profile

Financial Performance

In 2025, T.Man Pharmaceutical PCL's revenue was 2.53 billion, an increase of 13.48% compared to the previous year's 2.23 billion. Earnings were 523.07 million, an increase of 16.06%.

Financial Statements

News

There is no news available yet.